Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke "MACSI"


Phase 3 Results N/A

Summary of Purpose

The purpose of this trial is to determine if intravenous administration of the metal ion trapping agent DP-b99 up to 9 hours following acute ischemic stroke onset, and then for 3 additional days (4 consecutive days in total) is effective in improving long term outcome. Patients will be followed up for 3 months after the... Trial Stopped: The result of a pre-planned interim futility analysis

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 October 2012.

1 Dec 2009 4 May 2009 1 Apr 2012 1 Apr 2012 1 Oct 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment